Reps. DeFazio, Doggett Lead Members in Urging HHS to Lower Cost of Prostate Cancer Drug
February 08, 2022
February 08, 2022
WASHINGTON, Feb. 8 -- Rep. Peter DeFazio, D-Oregon, issued the following news release on Feb. 8, 2022:
U.S. Representatives Peter DeFazio (OR-04) and Lloyd Doggett (TX-35) today led Members of the House of Representatives in sending a letter to Secretary of Health and Human Services (HHS) Xavier Becerra urging him to follow through with Biden Administration's commitment to lowering exorbitant prescription drug costs.
Xtandi, a prostate cancer drug marketed by a Japanese . . .
U.S. Representatives Peter DeFazio (OR-04) and Lloyd Doggett (TX-35) today led Members of the House of Representatives in sending a letter to Secretary of Health and Human Services (HHS) Xavier Becerra urging him to follow through with Biden Administration's commitment to lowering exorbitant prescription drug costs.
Xtandi, a prostate cancer drug marketed by a Japanese . . .